However, an experimental approach that encompasses both in vitro assays using EGFR-expressing lung cancer cell lines and in vivo validation—providing a comprehensive understanding of the potential therapeutic implications of caffeic acid in suppressing lung cancer metastasis—is absolutely needed. This evidence concerns the gene EGFR and lung cancer.